Switch theme
Sign up to access all valuation multiples
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase’s products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.
1998
23
LTM Revenue $3.5M
LTM EBITDA -$6.9M
$12.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
SciBase Holding has a last 12-month revenue (LTM) of $3.5M and a last 12-month EBITDA of -$6.9M.
In the most recent fiscal year, SciBase Holding achieved revenue of $3.1M and an EBITDA of -$5.9M.
SciBase Holding expects next 12-month revenue of XXX and NTM EBITDA of XXX
See SciBase Holding valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5M | XXX | $3.1M | XXX | XXX | XXX |
| Gross Profit | $2.4M | XXX | $2.2M | XXX | XXX | XXX |
| Gross Margin | 70% | XXX | 71% | XXX | XXX | XXX |
| EBITDA | -$6.9M | XXX | -$5.9M | XXX | XXX | XXX |
| EBITDA Margin | -198% | XXX | -194% | XXX | XXX | XXX |
| EBIT | -$7.2M | XXX | -$6.9M | XXX | XXX | XXX |
| EBIT Margin | -207% | XXX | -225% | XXX | XXX | XXX |
| Net Profit | -$7.2M | XXX | -$6.3M | XXX | XXX | XXX |
| Net Margin | -206% | XXX | -206% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, SciBase Holding's stock price is SEK 0 (or $0).
SciBase Holding has current market cap of SEK 129M (or $13.3M), and EV of SEK 121M (or $12.5M).
See SciBase Holding trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12.5M | $13.3M | XXX | XXX | XXX | XXX | $-0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, SciBase Holding has market cap of $13.3M and EV of $12.5M.
SciBase Holding's trades at 4.1x EV/Revenue multiple, and -2.1x EV/EBITDA.
Equity research analysts estimate SciBase Holding's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SciBase Holding has a P/E ratio of -1.9x.
See valuation multiples for SciBase Holding and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13.3M | XXX | $13.3M | XXX | XXX | XXX |
| EV (current) | $12.5M | XXX | $12.5M | XXX | XXX | XXX |
| EV/Revenue | 3.6x | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBITDA | -1.8x | XXX | -2.1x | XXX | XXX | XXX |
| EV/EBIT | -1.7x | XXX | -1.8x | XXX | XXX | XXX |
| EV/Gross Profit | 5.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | -1.9x | XXX | -2.1x | XXX | XXX | XXX |
| EV/FCF | -1.9x | XXX | -2.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSciBase Holding's last 12 month revenue growth is 50%
SciBase Holding's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.4M for the same period.
SciBase Holding's rule of 40 is -172% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SciBase Holding's rule of X is -71% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for SciBase Holding and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 50% | XXX | 50% | XXX | XXX | XXX |
| EBITDA Margin | -198% | XXX | -194% | XXX | XXX | XXX |
| EBITDA Growth | -2% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -172% | XXX | -144% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -71% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 194% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 62% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 296% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SciBase Holding acquired XXX companies to date.
Last acquisition by SciBase Holding was XXXXXXXX, XXXXX XXXXX XXXXXX . SciBase Holding acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was SciBase Holding founded? | SciBase Holding was founded in 1998. |
| Where is SciBase Holding headquartered? | SciBase Holding is headquartered in Sweden. |
| How many employees does SciBase Holding have? | As of today, SciBase Holding has 23 employees. |
| Who is the CEO of SciBase Holding? | SciBase Holding's CEO is Ms. Pia Renaudin. |
| Is SciBase Holding publicy listed? | Yes, SciBase Holding is a public company listed on STO. |
| What is the stock symbol of SciBase Holding? | SciBase Holding trades under SCIB ticker. |
| When did SciBase Holding go public? | SciBase Holding went public in 2015. |
| Who are competitors of SciBase Holding? | Similar companies to SciBase Holding include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of SciBase Holding? | SciBase Holding's current market cap is $13.3M |
| What is the current revenue of SciBase Holding? | SciBase Holding's last 12 months revenue is $3.5M. |
| What is the current revenue growth of SciBase Holding? | SciBase Holding revenue growth (NTM/LTM) is 50%. |
| What is the current EV/Revenue multiple of SciBase Holding? | Current revenue multiple of SciBase Holding is 3.6x. |
| Is SciBase Holding profitable? | Yes, SciBase Holding is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of SciBase Holding? | SciBase Holding's last 12 months EBITDA is -$6.9M. |
| What is SciBase Holding's EBITDA margin? | SciBase Holding's last 12 months EBITDA margin is -198%. |
| What is the current EV/EBITDA multiple of SciBase Holding? | Current EBITDA multiple of SciBase Holding is -1.8x. |
| What is the current FCF of SciBase Holding? | SciBase Holding's last 12 months FCF is -$6.7M. |
| What is SciBase Holding's FCF margin? | SciBase Holding's last 12 months FCF margin is -194%. |
| What is the current EV/FCF multiple of SciBase Holding? | Current FCF multiple of SciBase Holding is -1.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
